{
    "ticker": "ILMN",
    "name": "Illumina, Inc.",
    "description": "Illumina, Inc. is a global leader in genomics and biotechnology, focused on improving human health by unlocking the power of the genome. Founded in 1998 and based in San Diego, California, Illumina is renowned for its innovative sequencing and array-based solutions that are used for applications in research, clinical settings, and diagnostics. The company's mission is to enable customers to leverage genomics to make significant advancements in healthcare, including personalized medicine, genetic disease research, and cancer genomics. Illumina's flagship products include its sequencing systems, such as the NovaSeq and NextSeq series, which provide high-throughput sequencing capabilities, as well as a range of bioinformatics tools for data analysis. The company is committed to driving down the cost of sequencing and increasing accessibility to genomic information. Illumina also collaborates with numerous academic institutions, healthcare organizations, and pharmaceutical companies to advance the integration of genomics into clinical practice. With a focus on innovation and a strong patent portfolio, Illumina continues to shape the future of genomics and its applications in improving patient outcomes.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "1998",
    "website": "https://www.illumina.com",
    "ceo": "Francis deSouza",
    "social_media": {
        "twitter": "https://twitter.com/illumina",
        "linkedin": "https://www.linkedin.com/company/illumina/"
    },
    "investor_relations": "https://investors.illumina.com",
    "key_executives": [
        {
            "name": "Francis deSouza",
            "position": "CEO"
        },
        {
            "name": "Samant Virk",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Sequencing Systems",
            "products": [
                "NovaSeq",
                "NextSeq",
                "MiSeq"
            ]
        },
        {
            "category": "Array Solutions",
            "products": [
                "Infinium Genotyping Services",
                "SNP Arrays"
            ]
        }
    ],
    "seo": {
        "meta_title": "Illumina, Inc. | Leading Genomics and Biotechnology Solutions",
        "meta_description": "Explore Illumina, Inc., a leader in genomics technology. Learn about their innovative sequencing systems and commitment to improving healthcare through genomics.",
        "keywords": [
            "Illumina",
            "Genomics",
            "Biotechnology",
            "DNA Sequencing",
            "Personalized Medicine",
            "Cancer Genomics"
        ]
    },
    "faq": [
        {
            "question": "What is Illumina known for?",
            "answer": "Illumina is known for its advanced sequencing technology and genomics solutions that enhance research and clinical applications."
        },
        {
            "question": "Who is the CEO of Illumina?",
            "answer": "Francis deSouza is the CEO of Illumina, Inc."
        },
        {
            "question": "Where is Illumina headquartered?",
            "answer": "Illumina is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Illumina's main products?",
            "answer": "Illumina's main products include sequencing systems like NovaSeq and NextSeq, as well as array solutions."
        },
        {
            "question": "When was Illumina founded?",
            "answer": "Illumina was founded in 1998."
        }
    ],
    "competitors": [
        "PACB",
        "MGEN",
        "BMY"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "ABBV"
    ]
}